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Objectives: The study defined the selection criteria used for treatment of ruptured abdominal aortic aneurysms (RAAAs)
and reviewed results during a 5-year period.
Methods: From 2002 on, our tertiary referral center adopted a protocol of selective use of endovascular repair for RAAAs.
The study included all patients with a proven RAAA who were admitted to our hospital from 2002 to 2006. The primary
outcome measure was surgical mortality.
Results: A total of 187 patients were admitted with an acute AAA, and an RAAA was confirmed 135 (72%) by computed
tomography scanning or at laparotomy, and 125 (93%) were treated, 89 by open means and 36 by endovascular means.
The overall mortality rate was 24% and the mortality rate was 13.9% for endovascular repair. Endovascular repair was
consistently used more often in patients with favorable anatomy and in patients who were hemodynamically more stable.
There were considerable differences in approach between the four consultant vascular surgeons. The overall evaluation
and inclusion for endovascular treatment increased during the study period.
Conclusions:A strict protocol for admission, evaluation, and treatment of RAAA, with selective use of endovascular repair,
resulted in low mortality rates in our center. ( J Vasc Surg 2008;48:1396-1400.)A meta-analysis of open repair of ruptured aortic ab-
dominal aneurysms (RAAAs) demonstrated a 30-day mor-
tality of 48%, with a constant reduction of only approxi-
mately 3.5% per decade (1954 to 1997) and with an
estimated 41% operative mortality rate for the year 2000.1
Since it was first used in 1994, endovascular repair (EVAR)
of RAAA has emerged as a promising alternative treatment
to open surgical repair.2-9 Two systematic reviews con-
firmed the potential benefits of EVAR for RAAAs.10,11 A
randomized controlled trial, which was terminated before
achieving the appropriate sample size due to poor enroll-
ment and use of inclusion criteria that are not generalizable
to many centers using endovascular repair for RAAA,
showed a 30-day mortality of 53% in both the open repair
and EVAR arm.12
The interpretation of current results from the literature
is difficult because of patient selection criteria, definition of
anatomic suitability for EVAR, and definition of hemody-
namic stability. In addition, as shown by the Albany
group,13 a standardized protocol for EVAR of RAAA needs
to be established. These factors are probably limiting the
From the Departments of Surgerya and Epidemiology,c University Medical
Center Groningen, Groningen; and the Department of Surgery, Onze
Lieve Vrouwe Gasthuis, Amsterdam.b
Competition of interest: Dr Verhoeven has received consulting fees and
research grants from William Cook Europe and W. L. Gore and
Associates.
Correspondence: Eric L. G. Verhoeven, MD, PhD, Department of Surgery,
Division of Vascular Surgery, University Medical Center Groningen,
Hanzeplein 1, PO Box 30,001, 9700 RB Groningen, The Netherlands
(e-mail: e.l.g.verhoeven@chir.umcg.nl).
0741-5214/$34.00
Copyright © 2008 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2008.07.054
1396use of EVAR in RAAA, and many centers are still offering
only open repair.
In 2002 we adopted a protocol of selective use of
EVAR for RAAA, and encouraged by the results, we have
continued to offer both treatment modalities.14 The pur-
pose of this study was to define the selection criteria that we
used for each treatment modality and to review results
during a 5-year period.
PATIENTS AND METHODS
This study was conducted in a tertiary vascular center
with expertise in EVAR as defined by Forbes et al15 and
after a preceding feasibility trial of which the results have
been reported elsewhere.14
Study design. As of January 1, 2002, all patients with
an acute RAAA were recorded, and those entered between
2002 and 2006 were included in this study. An aneurysm
was defined as ruptured when blood was identified outside
the aorta on computed tomography (CT) scanning or as a
retroperitoneal hematoma found at laparotomy. All other
AAA patients, including those with an acute, nonruptured
AAA, were excluded.
Our management protocol for acute AAA has been
described before.6,14 In brief, evaluation of each patient
was done simultaneously by the on-call vascular surgeon,
the anesthetist, and an interventional radiologist. When-
ever possible, a CT scan was immediately ordered to con-
firm the diagnosis and to evaluate suitability for EVAR.
Intravenous fluid infusion was minimized, and hypotension
was accepted as long as the patient remained conscious with
coherent verbal responses. The decision to order a CT scan
was left to the on-call team rather than defining a lowest
blood pressure threshold.
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decision not to evaluate the patient for EVAR because of
hemodynamic instability, open treatment was initiated
without further delay. Anatomic suitability for EVAR was
evaluated according to guidelines for elective EVAR, in-
cluding proximal neck length 1.5 cm with 60° angula-
tion and access vessels large enough (7 mm) to accommo-
date the introducer systems. However, in selected cases, a
neck length between 5 and 15 mm was also considered for
EVAR.
Local anesthesia was the preferred choice for EVAR,
with additional intravenous sedation and analgesia if re-
quired. General anesthesia was used only if patient cooper-
ation proved insufficient or in combination with an aortou-
niiliac (AUI) device, followed by a crossover bypass. In that
case the procedure was started under local anesthesia and
converted to general anesthesia after insertion of the AUI.
The preferred endovascular graft configuration was a
bifurcated prosthesis. AUI configuration was used only if
a bifurcated device was contraindicated due to insuffi-
cient bilateral access. The surgical technique of EVAR, as
well as the use of local anesthesia, is described elsewhere
in detail.14
Outcome measures. The primary clinical outcome
was mortality (30-day mortality and hospital mortality).
Secondary outcomes were duration of procedure, intensive
care unit and hospital length of stay, transfusion require-
ments, early and late complications, reinterventions, and
long-term survival.
Statistical analysis. Data were prospectively entered
in a database, and analyses were conducted using SPSS 15.1
software (SPSS Inc, Chicago Ill). Variables were expressed
as median  standard deviation. The t test and Mann-
Whitney U test were used for comparison of continuous
variables with normal and skewed distributions, respec-
tively. The Pearson 2 test was used for categoric variables,
and the Kruskal-Wallis test was used for more than two
variables. Survival was analyzed using Kaplan-Meier curves
and log-rank testing. Differences were considered statisti-
cally significant with a value of P  .05.
RESULTS
Patient admission. During a 5-year period, 187 pa-
tients were admitted with an acute AAA; of these, 52 were
excluded (49 had a nonruptured acute AAA, 2 had an
aortoduodenal fistula, and 1 had a suprarenal mycotic
aneurysm), leaving 135 patients with a RAAA. Their me-
dian age was 72  8.7 years, and 116 (86%) were men.
General practitioners had referred 99 patients (73%) di-
rectly through ambulance services. No patient who was
announced by ambulance services died during transport.
Another 32 patients (24%) were referred from other hospi-
tals, 23 because no intensive care unit was available and
nine because the local hospital lacked surgical expertise at
that moment. Four patients were internal referrals (2 from
the dialysis unit, 1 from the coronary care unit, and 1 from
the recovery unit after a laparotomy).At the time of admission, 77 patients (group I) were
regarded stable with a systolic blood pressure of 100
mm Hg, 24 patients (group II) had a systolic blood
pressure between 70 and 100 mmHg, and the remaining
34 patients (group III) had a systolic blood pressure of
70 mm Hg.
Evaluation and treatment. Evaluation for EVAR oc-
curred in 104 patients (77%). No evaluation was done in 31
patients, including four who received no treatment. Three
patients were not treated because of advanced age and
comorbidity, and one patient died shortly after arrival. In
the remaining 27 patients, 23 were not evaluated because
of hemodynamic instability in 21 or unrest due to pain in 2
(1 group I, 2 group II, 20 group III). Three patients were
not evaluated for logistic reasons: no endovascular team
was available (n 2) and a second endovascular procedure
was not possible (n  1). The reasons one patient was not
evaluated are unknown.
Treatment was initiated in 125 patients (93%), and 10
patients were not treated, including six who were evaluated
but were not suitable for EVAR. Open treatment was done
in 89 patients (71%), and 36 (29%) had EVAR. Open
treatment was done in 27 patients who were not evaluated
for EVAR as mentioned and in 62 patients who underwent
a CT scan. Of these 62 patients, 26 were unsuitable for
EVAR due to an overly short proximal neck, 16 due to an
aortoiliac aneurysm to both iliac bifurcations, 7 due to
insufficient access, and 13 due to a combination of previous
reasons. Open treatment was initiated significantly more in
hemodynamically unstable patients (P .001, Fig 1). In 31
of 89 patients (35%) who had open repair, suprarenal
clamping was necessary but no renal artery reconstruction
was performed.
Evaluation for EVAR increased from 62.5% in the first
year to 80% and more in the last 3 years of the study. The
percentage of patients treated by EVAR increased gradu-
ally, from 18% to 37.5%, during the 5-year study period
(Fig 2). There was a significant difference in patient selec-
tion for EVAR by the surgeon who was on-call, varying
from 45% to 8% (Fig 3, P  .001).
The time to the start of the procedure was significantly
shorter in the patient group treated by open means without
CT scanning (median 26  20 minutes) vs EVAR and CT
scanning (median 45  24 min) and open repair plus CT
scanning (median 45  33 minutes; P  .001).
Of the 36 EVAR procedures, 30 (83%) were per-
formed under local anesthesia only. Three additional
procedures were started under local anesthesia but re-
quired general anesthesia afterwards, two to evacuate
hematoma causing an abdominal compartment syndrome,
and one because of asystolia. Two patients were initially
treated under general anesthesia because of unrest, and one
stable obese patient was treated under epidural anesthesia.
Device distribution was 31 Zenith Tri-Fab devices and
one Zenith AUI system (Cook Inc, Bloomington, Ind);
three Excluder devices (W. L. Gore and Associates, Flag-
staff, Ariz); and one patient was treated with a Zenith
Tri-Fab body in conjunction with Excluder limbs.
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with open repair (median 85  27 vs 200  62 minutes,
P  .001). Transfusion requirement of packed cells (me-
dian 0  4 vs 5  6 U), intensive care unit stay (median
0  85 vs 72  246 hours), and hospital stay (median 5
10 vs 20 20 days) were all in favor of EVAR (P .001 for
each factor).
Mortality. Overall mortality by intention-to-treat was
27% (36 of 131), with only four patients (3%) denied
treatment. This includes the six patients who were evalu-
ated for EVAR but were unsuitable and denied open treat-
ment due to age and comorbidity.
Mortality as per on-treatment, with 93% of all RAAA
treated, was 24% (30 of 125), with an open mortality of
28.1% (25 of 89) and EVAR mortality of 13.9% (5 of 6;
P  .092).
Mortality according to hemodynamic stability and
treatment modality is compiled in the Table, with the
highest mortality in group III. (Kruskal-Wallis test: P 
0.193 for open repair, P  0.042 for EVAR, P  .051 for
total group.)
Mortality per surgeon was not statistically different for
Fig 1. Number of patients with ruptured abdominal aortic aneu-
rysm treated by open means and by endovascular repair (EVAR)
according to hemodynamic stability at arrival in emergency depart-
ment. SBP, Systolic blood pressure.
Fig 2. Percentage of patients evaluated for endovascular aneu-
rysm repair (EVAR, diamonds) and treated by EVAR (squares)
during the study period.the four attending vascular surgeons (excluded were the13 patients operated on by other surgeons, with or
without a consultant vascular surgeon): 28.9% (11 of 38)
for surgeon I, 22.2% (6 of 27) for surgeon II, 31.8% (7 of
22) for surgeon III, and 20% (5 of 25) for surgeon IV
(Kruskal-Wallis test, P  .75).
Complications. Three (8.3%) EVAR patients re-
quired reintervention, two for an abdominal compartment
syndrome and one for an ischemic colon in conjunction
with an abdominal compartment syndrome. Reinterven-
tion was required in 24 open patients (28.1%) for postop-
erative bleeding in 8, ischemic colon in 7, limb ischemia in
6, sepsis in 3, and abdominal fascia dehiscence in 1. The
30-day reintervention rate was lower with EVAR than with
open repair (8.3% vs 28.1%, P  .01).
Follow-up. During the follow-up of 25 months
Fig 3. Selection for endovascular aneurysm repair (EVAR, gray
bars) and open repair (black bars) by individual vascular surgeon,
with total number of treated patients between brackets.
Fig 4. Kaplan-Meier survival curve for patients with ruptured
abdominal aortic aneurysm treated with endovascular aneurysm
repair (EVAR (solid line) and open repair (dotted line) (P  .24,
SE 10% at 3 years for EVAR and 4 years for open repair).(range, 1-64 months), 16 patients died. Fig 4 shows the
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 6 Verhoeven et al 1399survival curve according to treatment modality. There was
no statistical difference in survival between EVAR and open
repair (P .24). Eleven patients died of probably unrelated
causes (5 cardiac, 3 pulmonary, 1 ruptured type A dissec-
tion, 1 malignancy, 1 age), three of indeterminate aneu-
rysm-related causes (2 unknown, 1 probable rupture of
thoracic aneurysm), and two of aneurysm-related causes
(1 due to sepsis after 2 months, 1 due to pneumonia after 2
months, both open repairs).16
Late reinterventions were performed in four of the 95
surviving patients. One EVAR patient presented with a
painful AAA after 42 months due to disconnection of both
graft limbs. This was immediately treated by endovascular
means with bridging stent grafts.17 Three open-treated
patients underwent four reinterventions. The first patient
had two procedures, one at 5 months to re-establish bowel
continuity and another at 24 months to correct an inci-
sional hernia. The second patient had an incisional hernia
repaired at 46 months. Finally, the third patient underwent
coiling of an internal iliac aneurysm after 18 months.
DISCUSSION
This study evaluates the first 5 years of a strategy of
offering EVAR and open repair to patients with a RAAA
according to hemodynamic and anatomic criteria. Mortal-
ity rates both with open repair (28.1%) and EVAR (13.9%)
compare well with the available literature.1,10,11 Overall
mortality was 24%, which is remarkably low, especially if
one considers that 93% of all admitted patients were
treated. Basnyat et al18 reported that about 50% of all
patients with a RAAA were refused treatment.
In our series, only 10 patients (7%) were not treated.
Four patients were denied treatment on admission (2 died
1 hour) because of age and comorbidity. An additional
six patients who were evaluated but not suitable for EVAR
ultimately did not undergo open repair because two refused
and four were determined to be totally unfit for open repair.
The low mortality rates both in open repair and EVARmay
have been influenced by the protocol requiring the pres-
ence of a senior vascular surgeon even before admission of
the patient. Open repair after evaluation with CT scan adds
anatomic information for the operating surgeon, which
may improve outcome.
Hemodynamically unstable patients (group III) had a
worse outcome compared with more stable patients on
admission. These patients were immediately treated with
open repair, but with a mortality rate of 37.9%, results are
still in range with the current literature. Evaluation for
Table. Mortality of ruptured abdominal aortic aneurysm a
Procedure Group I G
Open, No. (%) 12/44 (27.3) 2/1
EVAR, No. (%) 3/29 (10.3) 1/6
Total, No. (%) 15/73 (20.5) 3/2
EVAR, Endovascular aneurysm repair.EVAR by CT scan occurred in 77%. Themain reason not toevaluate patients was hemodynamic instability during the
admission at the emergency department. During the study
period, both the evaluation of patients for EVAR as the
ratio of patients treated by EVAR increased (Fig 2). This is
probably explained by a 24 hours a day, 7 days a week,
multidisciplinary on-call system for RAAA, including a
vascular surgeon, interventional radiologist, and radiology
technicians, who are in the hospital at all times.
The availability of a 64-multi-slice CT scan in the
emergency department is another important asset, and total
time for CT scanning and evaluation of the images was30
minutes. Another possible explanation to allow for evalua-
tion with a CT scan may be the strict fluid restriction
protocol applied both by the ambulance services and our
emergency department. Indeed, 57% of patients were sta-
ble (group I) at arrival, and only 25% were hemodynami-
cally unstable (group III).
A comparison between EVAR and open repair seems
inappropriate, because of an obvious bias created by ana-
tomic selection criteria and hemodynamic stability on ad-
mission. Open repair was clearly used in more complex
cases and unstable patients, which required more extensive
dissection and even suprarenal clamping in 35%. This af-
fects not only mortality rates but also time events such as
operation time, blood transfusion requirement (eg, due to
larger retroperitoneal hematoma), complication rates, and
intensive care unit and hospital length of stay. To our
surprise, survival curves were parallel, although the open
repair patients presented with more complex aneurysms.
Although the option to treat patients with suitable
RAAA by EVAR under local anesthesia presents with un-
deniable potential advantages, as shown in many cohort
studies, scientific proof is lacking.2-9 A recently published
nationwide survey in the United States concluded that
EVAR is being increasingly used, with steadily decreasing
mortality rates, but differences in patient disease, selection,
or timing of intervention could not be appreciated from the
data.19 This obviously adds to the question of the validity of
the conclusions, in view of the same bias (easier anatomy
and more stable patients). In our opinion, open repair and
EVAR should be regarded as complementary techniques to
improve outcome of patients with a RAAA.
Whether EVAR without CT scan is an option for
patients who are unstable remains open. Some have sug-
gested this approach, but scientific proof is lacking.13 Our
results seem to indicate otherwise (Table). Group III had a
mortality rate of 37.9%, and attempting EVAR in a few
suitable cases with questionable outcome might impair the
ding to hemodynamic stability and treatment modality
II Group III Total
.5) 11/29 (37.9) 25/89 (28.1)
7) 1/1 (100) 5/36 (13.9)
.6) 12/30 (40) 30/125 (24)ccor
roup
6 (12
(16.
2 (13outcome of the remaining patients who in the end still need
JOURNAL OF VASCULAR SURGERY
December 20081400 Verhoeven et alopen repair but with a considerable delay of treatment.
Obviously, we have only limited experience with EVAR in
unstable patients (group II and III).
The major limitation of this study is treatment selec-
tion. Comparing the two technical options remains biased,
and only a randomized trial might provide the answer. Such
a trial is currently ongoing, and results are expected later
this year.20
Another important limitation that may explain our
good results is patient bias. Indeed, our tertiary referral
center is regarded the first address for a patient with an
RAAA, but we cannot account for those patients who
were too unstable to be transported to us and were taken
to a nearby regional hospital. Although some of these
patients were later still referred to us, others may have died
in surgery or on the way to the local hospital. Compared
with other regions worldwide, distances are short in The
Netherlands—rarely more than 1-hour transport time—
even to our center, and ambulance services are well orga-
nized.21
Finally, although EVAR in elective patients has higher
procedural costs than open repair, this seems not to be the
case in acute EVAR. Indeed, a cost analysis on a subgroup
of patients demonstrated a benefit in favor of EVAR in two
studies, including our own patient population.22,23
CONCLUSION
The capability of offering EVAR and open repair for
RAAA according to hemodynamic and anatomic criteria
seems to be associated with improved survival.
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